Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 285

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Current State of Immunotherapy for Treatment of Glioblastoma

Open access
McGranahan, Tresa, Therkelsen, Kate Elizabeth, Ahmad, Sarah, Nagpal, Seema · 2019 · Current Treatment Options in Oncology

Abstract

OPINION STATEMENT: At this time, there are no FDA-approved immune therapies for glioblastoma (GBM) despite many unique therapies currently in clinical trials. GBM is a highly immunosuppressive tumor and there are limitations to a safe immune response in the central nervous system. To date, there have been several failures of phase 3 immune therapy clinical trials in GBM. These trials have targeted single components of an antitumor immune response. Learning from these failures, the future of immunotherapy for GBM appears most hopeful for combination of immune therapies to overcome the profound immunosuppression of this disease. Understanding biomarkers for appropriate patient selection as well as tumor progression are necessary for implementation of immunotherapy for GBM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11864-019-0619-4

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

See all 285

Metadata

Authors
McGranahan, T., Therkelsen, K. E., Ahmad, S., & Nagpal, S.
Venue
Current Treatment Options in Oncology
Published
2019-02-21
Volume
20
Issue
3
Pages
24-24
ISSN
  • 1527-2729 (ISSN-L)
  • 1534-6277
OpenAlex
W2916332433
Cited by
285
References
64
FWCI
20.95
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current State of Immunotherapy for Treatment of Glioblastoma. https://app.cochat.ai/papers/10.1007/s11864-019-0619-4
The paper
McGranahan, T., Therkelsen, K. E., Ahmad, S., & Nagpal, S. (2019). Current State of Immunotherapy for Treatment of Glioblastoma. Current Treatment Options in Oncology. https://doi.org/10.1007/s11864-019-0619-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.